» Articles » PMID: 37944076

Temporal Changes in Vaccine-Specific Willingness Across Race/Ethnicity Following Serious Adverse Event Reports

References
1.
Hsieh Y, Rak S, SteelFisher G, Bauhoff S . Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States. Vaccine. 2021; 40(3):424-427. PMC: 8664657. DOI: 10.1016/j.vaccine.2021.11.085. View

2.
Gortz M, Brewer N, Hansen P, Ejrnaes M . The contagious nature of a vaccine scare: How the introduction of HPV vaccination lifted and eroded MMR vaccination in Denmark. Vaccine. 2020; 38(28):4432-4439. DOI: 10.1016/j.vaccine.2020.04.055. View

3.
McElfish P, Willis D, Shah S, Bryant-Moore K, Rojo M, Selig J . Sociodemographic Determinants of COVID-19 Vaccine Hesitancy, Fear of Infection, and Protection Self-Efficacy. J Prim Care Community Health. 2021; 12:21501327211040746. PMC: 8388227. DOI: 10.1177/21501327211040746. View

4.
Azarpanah H, Farhadloo M, Vahidov R, Pilote L . Vaccine hesitancy: evidence from an adverse events following immunization database, and the role of cognitive biases. BMC Public Health. 2021; 21(1):1686. PMC: 8444164. DOI: 10.1186/s12889-021-11745-1. View

5.
Self W, Tenforde M, Rhoads J, Gaglani M, Ginde A, Douin D . Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(38):1337-1343. PMC: 8459899. DOI: 10.15585/mmwr.mm7038e1. View